Starting Wegovy at 2.4mg: why skipping the dose ladder matters

What the dose ladder is actually for, and what breaks when you skip it

Most people searching this question are frustrated with slow titration. That frustration is understandable. The full maintenance dose is where the clinical trial results live, and the early doses can feel underwhelming. But the low starting doses are not conservative timidity on the part of regulators. They are doing a specific job.

Semaglutide slows gastric emptying markedly. At 0.25mg, your digestive system begins adjusting to that effect. Nausea at this stage is typically mild and settles within a week or two. At 2.4mg, that same slowing is several times more pronounced. Without the preceding weeks of adaptation, the GI response can be severe: persistent vomiting, dehydration, inability to keep food down. Some people require hospital treatment for dehydration when they have taken doses far above their tolerance.

The licensed schedule for Wegovy runs 0.25mg for four weeks, then 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg, each step held for at least four weeks. If you want to understand what happens at the 1.7mg stage specifically, the 1.7mg dose page covers that transition in detail. The point is that each rung prepares your system for the next. Remove the rungs and you do not arrive at maintenance faster; you arrive at a wall of side effects.

This is not a bureaucratic rule. It is pharmacology.

The decision most people are actually facing

Sometimes this search comes from people who have been prescribed Wegovy but feel their titration is moving too slowly. Sometimes it comes from people who have obtained a pen informally and are wondering whether to inject immediately at full dose. These are very different situations with a common thread: a prescriber's judgment is missing from the picture.

For people on a legitimate prescription, the right move is a conversation with your prescriber or pharmacist, not an independent dose jump. Prescribers can, in some circumstances, extend a dose stage if your body needs longer. They can also give you practical advice on managing nausea during escalation, eating small meals, staying hydrated, timing the injection. That clinical relationship is what you are paying for when you use a regulated service.

For people considering buying Wegovy from an unverified source, the risks compound. You may receive a counterfeit product. The MHRA has warned publicly about fake weight-loss pens seized in the UK, some containing entirely different substances. A pen that arrives without a prescription and without clinical oversight carries risks that go well beyond side effects. You can verify any online pharmacy on the GPhC register before handing over personal or medical details.

The guide to buying Wegovy online safely covers what a legitimate supply chain looks like and what red flags to watch for.

What the evidence actually says about 2.4mg, and why it is worth reaching

The 2.4mg dose is genuinely where the meaningful results sit. In the STEP 1 trial, published in the New England Journal of Medicine, adults using semaglutide 2.4mg alongside lifestyle changes lost an average of around 15% of their body weight over 68 weeks. That figure reflects participants who reached and stayed at the maintenance dose, not people who stopped at 1.0mg because they could not tolerate further escalation.

Reaching 2.4mg is therefore the goal, and if you are wondering what starting at 1mg means for your treatment, that page explains exactly what to expect at that stage. If you have concerns about how your titration is progressing, the full Wegovy dose guide sets out what each stage involves and when it typically moves forward. For context on how Wegovy compares with tirzepatide at their respective maintenance doses, the weight-loss treatments overview is a good starting point.

Cost is sometimes the reason people want to compress the schedule, fewer pens, lower monthly spend. The reality is that the 0.25mg and 0.5mg starter pens are part of treatment, not optional extras. Any provider quoting a price for Wegovy should be pricing the full schedule. A transparent cost structure, including what is and is not covered across the titration period, matters more than the headline monthly figure.

What happens if you genuinely need to reassess your dose

Missing doses, falling ill during titration, or experiencing persistent side effects can all create situations where the right next step is not obvious. Missing a dose has specific implications depending on how much time has passed. Taking more than prescribed (including anything resembling a double dose) carries its own risks covered on the double-dose page.

The short answer in all these scenarios is the same: your prescriber or the Patient Information Leaflet that came with your pen is the right reference, not a forum or a search result. At nume, our prescribers are available seven days a week for aftercare questions. Your consultation and every repeat order is reviewed by a real clinician, the same day you submit it, not queued for automated processing. If you are not yet a patient and want to understand whether Wegovy is clinically appropriate for your situation, you can check your eligibility with a free consultation.